Scott M. Wunsch - 30 Jul 2026 Form 4 Insider Report for Strata Critical Medical, Inc. (SRTA)

Reporting relationship: CEO, Logistics
Issuer ticker: SRTA
Reported as of: 30 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 Oct 2026, 16:06:20 UTC
Prior SEC filing: 18 Jun 2026
Next SEC filing: 10 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Melissa M. Tomkiel, Attorney-in-fact for Scott M. Wunsch

Filing notes and source

Key filing fact

Scott M. Wunsch filed Form 4 for Strata Critical Medical, Inc. (SRTA) on 30 Oct 2026.

Key facts

This page summarizes Scott M. Wunsch's Form 4 filing for Strata Critical Medical, Inc. (SRTA).
6 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 30 Oct 2026, 16:06.

Change

Previous filing in this sequence was filed on 18 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002027324 Primary reporting owner

Wunsch Scott M

Relationship: CEO, Logistics
Address: C/O STRATA CRITICAL MEDICAL, INC., 666 THIRD AVENUE, 25TH FLOOR, NEW YORK
Signature: /s/ Melissa M. Tomkiel, Attorney-in-fact for Scott M. Wunsch
Signature date: 30 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRTA transaction

Class A common stock, $0.0001 par value per share

Award

Transaction value
Shares: +9,787
Change %: +1.5%
Price: $0.000000^*
Shares after: 672,830
Date: 30 Jul 2026
Ownership: Direct
Footnotes: F1

SRTA transaction

Class A common stock, $0.0001 par value per share

Award

Transaction value
Shares: +2,658
Change %: +0.4%
Price: $0.000000^*
Shares after: 675,488
Date: 30 Jul 2026
Ownership: Direct
Footnotes: F2

SRTA transaction

Class A common stock, $0.0001 par value per share

Award

Transaction value
Shares: +57,173
Change %: +8.5%
Price: $0.000000^*
Shares after: 732,661
Date: 28 Oct 2026
Ownership: Direct
Footnotes: F3

SRTA transaction

Class A common stock, $0.0001 par value per share

Award

Transaction value
Shares: +57,173
Change %: +7.8%
Price: $0.000000^*
Shares after: 789,834
Date: 28 Oct 2026
Ownership: Direct
Footnotes: F3

SRTA transaction

Class A common stock, $0.0001 par value per share

Award

Transaction value
Shares: +1,416
Change %: +0.18%
Price: $0.000000^*
Shares after: 791,250
Date: 28 Oct 2026
Ownership: Direct
Footnotes: F4

SRTA transaction

Class A common stock, $0.0001 par value per share

Tax liability

Transaction value
Shares: -44,996
Change %: -5.7%
Price: $4.76^*
Shares after: 746,254
Date: 28 Oct 2026
Ownership: Direct
Footnotes: F5

SRTA holding

Class A common stock, $0.0001 par value per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 382,987
Date: 30 Jul 2026
Ownership: See Footnotes
Footnotes: F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Represents a grant of Restricted Stock Units ("RSUs") which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will vest on September 8, 2026, subject to the Reporting Person's continued service to the Issuer. The RSUs represent an award under the Reporting Person's quarterly commission program.

Footnote F2

Represents a grant of RSUs which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will vest on December 8, 2026, subject to the Reporting Person's continued service to the Issuer. The RSUs represent an award under the Reporting Person's quarterly commission program.

Footnote F3

Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 20, 2025.

Footnote F4

Represents a grant of RSUs which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will vest on March 8, 2027, subject to the Reporting Person's continued service to the Issuer. The RSUs represent an award under the Reporting Person's quarterly commission program.

Footnote F5

Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs.

Footnote F6

Held directly by a limited liability company of which the Reporting Person is the sole member.